Evidence map›Paper›PMID 23963039›Full record

ArticleBlood2013

Partial IFN-γR2 deficiency is due to protein misfolding and can be rescued by inhibitors of glycosylation.

Marcela Moncada-Vélez, Rubén Martinez-Barricarte, Dusan Bogunovic, Xiao-Fei Kong, Lizbeth Blancas-Galicia, Cengiz Tirpan, Guzide Aksu, Quentin B Vincent, Bertrand Boisson, Yuval Itan and 15 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Blood, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Inherited human IFN-γ deficiency underlies mycobacterial disease.The Journal of clinical investigation · 2020
    Article
  11. Review
  12. A Novel Splice Site Mutation inFrontiers in immunology · 2019
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

25 authors at 8 institutions in 5 countries.

Marcela Moncada-VélezSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY;
Rubén Martinez-Barricarte
Dusan Bogunovic
Xiao-Fei Kong
Lizbeth Blancas-Galicia
Cengiz Tirpan
Guzide Aksu
Quentin B Vincent
Bertrand Boisson
Yuval Itan
Noé Ramírez-Alejo
Satoshi Okada
Alexandra Y Kreins
Vanessa L Bryant
Jose Luis Franco
Mélanie Migaud
Sara Espinosa-Padilla
Marco Yamazaki-Nakashimada
Francisco Espinosa-Rosales
Necil Kutukculer
Laurent Abel
Jacinta Bustamante
Guillaume Vogt
Jean-Laurent Casanova
Stéphanie Boisson-Dupuis
Rockefeller University · USUniversité Paris Cité · FREge University · TRInstitut des Maladies Génétiques Imagine · FRCenter for Research and Advanced Studies of the National Polytechnic Institute · MXInserm · FRMardin Artuklu University · TRUniversidad de Antioquia · CO

Funding

Transforming Translational Science and Education to Benefit Human HealthUL1TR000043 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY · 2012 to 2015
$26.8M
Genome-Wide Dissection of Mendelian Susceptibility to Mycobacterial DiseaseR37AI095983 · NIAID · ROCKEFELLER UNIVERSITY · PI CASANOVA, JEAN-LAURENT · 2011 to 2020
$4.6M
A genetic dissection of Mendelian susceptibility to mycobacterial diseases (MSMD)R01AI089970 · NIAID · ROCKEFELLER UNIVERSITY · PI CASANOVA, JEAN-LAURENT · 2010 to 2014
$2.5M
European Research Council 268777NCATS NIH HHS 8UL1TR000043NCATS NIH HHS UL1 TR000043NIAID NIH HHS 1R01AI089970NIAID NIH HHS R01 AI089970NIAID NIH HHS R37 AI095983
6 · The paper itself

Abstract

We report a molecular study of the two known patients with autosomal recessive, partial interferon-γ receptor (IFN-γR)2 deficiency (homozygous for mutations R114C and G227R), and three novel, unrelated children, homozygous for S124F (P1) and G141R (P2 and P3). IFN-γR2 levels on the surface of the three latter patients' cells are slightly lower than those on control cells. The patients' cells also display impaired, but not abolished, response to IFN-γ. Moreover, the R114C, S124F, G141R and G227R IFNGR2 hypomorphic alleles all encode misfolded proteins with abnormal N-glycosylation. The mutants are largely retained in the endoplasmic reticulum, although a small proportion reach and function at the cell surface. Strikingly, the IFN-γ response of the patients' cells is enhanced by chemical modifiers of N-glycosylation, as previously shown for patients with gain-of-glysosylation T168N and misfolding 382-387dup null mutations. All four in-frame IFNGR2 hypomorphic mutant alleles encoding surface-expressed receptors are thus deleterious by a mechanism involving abnormal N-glycosylation and misfolding of the IFN-γR2 protein. The diagnosis of partial IFN-γR2 deficiency is clinically useful, as affected patients should be treated with IFN-γ, [corrected] unlike patients with complete IFN-γR2 deficiency. Moreover, inhibitors of glycosylation might be beneficial in patients with complete or partial IFN-γR2 deficiency due to misfolding or gain-of-glycosylation receptors.

Indexed as

AlkaloidsBase SequenceBlotting, WesternChildEnzyme InhibitorsFemaleFlow CytometryGenetic Predisposition to DiseaseGlycosylationHumansMaleMicroscopy, ConfocalMolecular Sequence DataMutationMycobacterium InfectionsPedigreeAlkaloidsEnzyme InhibitorsIFNGR2 protein, humankifunensineReceptors, Interferon

Identifiers

PMID23963039
PMCPMC3790508
OpenAlexW1969741509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.